美国食品药品监督管理局(FDA)已批准美敦力的Minimed 780G系统与Abbott公司生产的Instinct传感器进行集成,同时批准该系统用于2型糖尿病患者的治疗。
美国食品药品监督管理局(FDA)已批准美敦力的Minimed 780G系统与Abbott公司生产的Instinct传感器进行集成,同时批准该系统用于2型糖尿病患者的治疗。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.